Table 3.
Univariable and multivariable analyses luminal B BC with MPE at different age for overall survival
Variables | age < 50 years | P | age > 50 years | P | ||
---|---|---|---|---|---|---|
HR | CI 95%) | HR | CI (95%) | |||
Univariable analyses | ||||||
Clinical stages at initial diagnosis | 0.013 | 0.151 | ||||
Stage I | 0.103 | 0.018–0.602 | 0.395 | 0.064–2.417 | ||
Stage II | 0.331 | 0.102–1.075 | 0.294 | 0.066–1.321 | ||
Stage III | 1.139 | 0.391–3.320 | 1.359 | 0.395–4.678 | ||
Unknown | REF | REF | REF | REF | ||
Her2 expression | 2.781 | 0.915–8.449 | 0.071 | 0.818 | 0.269–2.487 | 0.723 |
Neoadjuvant | 0.954 | 0.422–2.156 | 0.909 | 3.755 | 0.724–19.483 | 0.115 |
Surgical approach | 2.459 | 0.915–6.605 | 0.074 | 0.152 | 0.016–1.466 | 0.103 |
Adjuvant Chemotherapy | 0.166 | 0.057–0.486 | 0.001 | 3.975 | 0.514–30.740 | 0.186 |
Adjuvant Endocrine therapy | 1.019 | 0.461–2.252 | 0.963 | 1.145 | 0.462–2.838 | 0.770 |
Adjuvant Radiotherapy | 0.563 | 0.270–1.174 | 0.126 | 0.972 | 0.384–2.460 | 0.952 |
Multivariable analysis | ||||||
Clinical stages at initial diagnosis | 0.026 | |||||
Stage I | 0.173 | 0.027–1.112 | - | - | ||
Stage II | 0.574 | 0.153–2.151 | - | - | ||
Stage III | 1.887 | 0.600-5.935 | - | - | ||
Unknown | REF | REF | - | - |